From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer’s Disease

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and represents a major public health challenge. With increasing life expectancy, the incidence of AD has also increased, highlighting the need for early diagnosis and improved monitoring. Traditionally, diagnosis has relied on...

Descripció completa

Dades bibliogràfiques

Autors principals:	Luisa Agnello, Caterina Maria Gambino, Anna Maria Ciaccio, Francesco Cacciabaudo, Davide Massa, Anna Masucci, Martina Tamburello, Roberta Vassallo, Mauro Midiri, Concetta Scazzone, Marcello Ciaccio
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-07-01
Col·lecció:	Current Issues in Molecular Biology
Matèries:	diagnostic criteria Alzheimer’s disease biomarkers plasma CSF blood
Accés en línia:	https://www.mdpi.com/1467-3045/47/8/580
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!